Moderna, Inc. — Director's Dealing 2020

May 14, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Moderna, Inc. (MRNA)
CIK: 0001682852
Period of Report: 2020-05-13

Reporting Person: Andres Juan (See remarks)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-05-13	Common Stock	M	127500	$12.21	Acquired	127500	Direct
2020-05-13	Common Stock	S	1400	$61.16	Disposed	126100	Direct
2020-05-13	Common Stock	S	8371	$62.41	Disposed	117729	Direct
2020-05-13	Common Stock	S	16183	$63.17	Disposed	101546	Direct
2020-05-13	Common Stock	S	38089	$64.44	Disposed	63457	Direct
2020-05-13	Common Stock	S	46517	$65.28	Disposed	16940	Direct
2020-05-13	Common Stock	S	15640	$66.27	Disposed	1300	Direct
2020-05-13	Common Stock	S	1300	$66.89	Disposed	0	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-05-13	Stock Option (Right to Buy)	$12.21	M	127500	Disposed	2027-08-29	Common Stock (127500)	Direct

Footnotes

F1: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan.

F2: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $60.75 to $61.57. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F3: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $61.78 to $62.76. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F4: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $62.80 to $63.78. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F5: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $63.83 to $64.83. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F6: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $64.84 to $65.84. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F7: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $65.85 to $66.78. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F8: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $66.88 to $66.91. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F9: 25% of this option vested and became exercisable on August 1, 2018 with the remainder vesting in 12 equal quarterly installments thereafter.